Viewing Study NCT05841134


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-31 @ 8:55 PM
Study NCT ID: NCT05841134
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-05-09
First Post: 2023-04-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer
Sponsor: The First Affiliated Hospital of Zhengzhou University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module